International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7844451
Original Article
Evaluation of Predictors of High Vasoactive Ionotropic Score Following Mitral Valve Replacement Surgery
 ,
 ,
Published
April 19, 2023
Abstract
This study was performed in patients undergoing mitral valve replacement surgery to know the effectiveness of predictors of high VIS (Vasoactive Inotropic Score), leading to increased requirements of inotropic supports post operatively, prolonged mechanical ventilation and ICU stay with increased morbidity and mortality. This prospective observational study was carried in cardiac operation theatre in a tertiary care hospital. 60 patients undergoing MVR were included under the study. Patient and surgical factors pre operatively and requirement of VIS post operatively, with any morbidity or mortality were studied. We found that mean age >60 years, female gender were associated with high VIS. Preoperative factors such as comorbidities (COPD, Hypertension, DM), EF between30-50%, severe pulmonary hypertension, severity of MS, hepatic and renal dysfunction have predictive value. Also, the intraoperative factors such as mean CPB time, mean aortic clamp time and duration of ventilation can predict the requirement of high VIS. Patients who require high VIS during mitral valve replacement surgery were at risk for prolonged mechanical ventilation and an extended ICU stay. Hence, through our study, we concluded that patients with the above mentioned predictors should be treated with caution.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
2082 Views
377 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved